NCT00001040View on ClinicalTrials.gov

Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

Not specified

Primary Completion Date

May 31, 1994

Conditions
HIV Infections
Interventions
DRUG

Saquinavir

DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (10)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

14642

Univ of Rochester Med Ctr, Rochester

35294

Univ of Alabama at Birmingham, Birmingham

60611

Northwestern Univ Med School, Chicago

80262

Univ of Colorado Health Sciences Ctr, Denver

98122

Univ of Washington, Seattle

191046073

Girard Med Ctr, Philadelphia

432101228

Ohio State Univ Hosp, Columbus

775550882

Univ TX Galveston Med Branch, Galveston

943055107

Stanford Univ Med Ctr, Stanford

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00001040 - Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC | Biotech Hunter | Biotech Hunter